AIRITY: A hybrid cross-sectional and prospective study to assess patient characteristics, disease burden, disease control, phenotypes, endotypes, and outcomes in a real-world setting in patients with asthma

Condition studied

Asthma

Investigational medicinal product(s)

Eligibility

Primary endpoint

1) Asthma control over time, including differences between people with well-controlled and poorly controlled asthma., 2) Changes in asthma treatment use, such as inhalers or other medicines., 3) Changes in lung function over time, based on repeated breathing tests, especially in groups defined by inflammation markers.

Endpoint detail

1) Asthma flare-ups, such as attacks needing extra medication, emergency care, or hospital visits., 2) Use of healthcare services, including doctor visits, emergency visits, and hospital stays., 3) Changes in asthma treatments, such as increases or decreases in medication use., 4) Other health conditions people with asthma may have and how severe they are., 5) Impact on daily life, including sleep quality, fatigue (tiredness), ability to do normal daily activities, and work or school productivity, 6) Patient and doctor views about asthma severity, symptom control, and satisfaction with treatment., 7) Changes in inflammation markers over time and how they relate to asthma symptoms and lung function.